Results 51 to 60 of about 7,028 (175)

The Therapeutic Efficacy of Drugs Targeting the NO‐sGC‐cGMP Pathway in Treatment of Patients With Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review

Pulmonary Circulation, Volume 16, Issue 3, July 2026.
ABSTRACT Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct and potentially curable form of pulmonary hypertension; however, a substantial proportion of patients remain inoperable or experience persistent or recurrent disease. Pharmacological therapies targeting the nitric oxide–soluble guanylate cyclase–cyclic guanosine monophosphate (
Abdullah A. Alqarni, Rawan H. Aljedani, Abdulelah M. Aldhahir, Ahmed H. Alasimi, Abdulkareem A. AlGarni, Jaber S. Alqahtani, Saeed Mardy Alghamdi, Rayan A. Siraj, Aminah Mengash, Hassan Alwafi   +9 more
wiley   +1 more source

Ocular hypotonia following pulmonary endarterectomy [PDF]

European Journal of Cardio-Thoracic Surgery, 2019
Abstract Significant fluid removal and negative fluid balance is typical of the management of patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary endarterectomy. In this study, we describe severe ocular hypotonia as an unusual clinical sign in a 72-year-old man immediately following pulmonary endarterectomy ...
Jason M Ali, Maksym Kovzel, Muhammad U Rafiq   +2 more
openaire   +2 more sources

Minimally Invasive Porcine Model for Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Circulation, Volume 16, Issue 3, July 2026.
ABSTRACT To elucidate the complex pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH), a disease associated with bilateral fibrotic obstructions of the pulmonary arteries (PA) and microvascular changes, research relies on animal models, which often depend on invasive techniques, including open surgery.
Bianca Battilana, Christian T. Stoeck, Fabien Robert, Ömer Senbaklavaci, Miriam Weisskopf, Isabelle Opitz   +5 more
wiley   +1 more source

Pulmonary endarterectomy for saddling pulmonary embolism by Aspergillus fungus in an immunocompetent patient

Indian Heart Journal, 2014
We present a case of Tricuspid valve Aspergillus endocarditis with saddle shaped massive pulmonary embolism occurring in an immunocompetent host. The patient was managed uniquely by pulmonary endarterectomy (PEA) and combination antifungal chemotherapy ...
Harpreet Singh Minhas, Gagan Jain, Chirantan Mangukia, Mayank Goyal   +3 more
doaj   +1 more source

Iron Homeostasis at High Altitude in Patients With Pulmonary Hypertension

Pulmonary Circulation, Volume 16, Issue 3, July 2026.
ABSTRACT Iron deficiency aggravates hypoxic pulmonary vasoconstriction, exacerbating the increase of pulmonary arterial pressure at high altitude (HA). This may be especially relevant for patients with pulmonary hypertension (PH) travelling to HA, who moreover have a high prevalence of iron deficiency. Currently, no data is available on iron parameters
Aurelia E. Reiser, Markus Thiersch, Max Gassmann, Simon R. Schneider, Laura Mayer, Stéphanie Saxer, Michael Furian, Richard Sparla, Esther I. Schwarz, Mona Lichtblau, Martina U. Muckenthaler, Silvia Ulrich   +11 more
wiley   +1 more source

Chronic thromboembolic pulmonary hypertension – surgical treatment options and our experience

Zdravniški Vestnik, 2009
Background: Chronic thromboembolic pulmonary hypertension is an increasingly recognized cause of pulmonary hypertension. Th e prognosis of untreated patients is poor.
Matevž Herlander, Barbara Salobir, Matjaž Turel, Boris Devčič, Marjeta Terčelj   +4 more
doaj  

Activin Signaling Inhibitors in Pulmonary Hypertension: A State‐of‐the‐Art Review

Pulmonary Circulation, Volume 16, Issue 3, July 2026.
ABSTRACT Pulmonary arterial hypertension (PAH) is a disease of abnormal pulmonary vascular remodeling and vascular obliteration that results in right heart failure and death. PAH pathogenesis is strongly associated with mutations of the Transforming Growth Factor Beta (TGF‐β) superfamily signaling pathway, which has previously been challenging to ...
Sudarshan Rajagopal, Joseph Abueg, Kevin M. Hart, Edmund Lau, Eliana C. Martinez, Nicholas W. Morrell, Ioana R. Preston, Sandeep Sahay, Namita Sood, Paul B. Yu, Nayeli G. Zayas‐Hernández   +10 more
wiley   +1 more source

Anesthetic management of chronic thromboembolic pulmonary hypertension for surgical pulmonary thromboendarterectomy: A narrative review

Journal of Anaesthesiology Clinical Pharmacology
Chronic thromboembolic pulmonary hypertension (CTEPH) is caused due to the total or partial occlusion of the pulmonary vasculature due to organized thrombus, leading to severe pulmonary hypertension and eventually right heart failure, which makes ...
Sambhunath Das, KG Krithika
doaj   +1 more source

Aseptic meningitis due to intravenous immunoglobulin therapy (IVIG) in therapy‐refractory pyoderma gangraenosum

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Katharina A. Kälber, Knut Schäkel, Alexander Enk, Julia K. Winkler   +3 more
wiley   +1 more source

Long‐Term Supervised Cardiac Rehabilitation After Balloon Pulmonary Angioplasty Improved Residual Exercise Pulmonary Hypertension in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Two‐Case Report

Pulmonary Circulation, Volume 16, Issue 3, July 2026.
ABSTRACT Abnormal pulmonary hemodynamics during exercise may persist even after balloon pulmonary angioplasty (BPA) for inoperable chronic thromboembolic pulmonary hypertension (CTEPH). We report two female patients who underwent long‐term supervised outpatient cardiac rehabilitation (CR) after BPA with continuous pulmonary vasodilators.
Yuya Suzuki, Yoshihisa Nakano, Katsuhiro Okazaki, Momoko Ito, Anna Yoshimori, Mai Tsunoda, Masahiro Yoshida, Toko Mitsui, Shiro Adachi, Akira Kimura   +9 more
wiley   +1 more source